Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Max India Ltd

MAXIND
NSE
155.34
0.20%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Max India Ltd

MAXIND
NSE
155.34
0.20%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
816Cr
Close
Close Price
155.34
Industry
Industry
Finance - Holding Company
PE
Price To Earnings
PS
Price To Sales
4.90
Revenue
Revenue
166Cr
Rev Gr TTM
Revenue Growth TTM
11.70%
PAT Gr TTM
PAT Growth TTM
28.29%
Peer Comparison
How does MAXIND stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
MAXIND
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
564149414526433542374543
Growth YoY
Revenue Growth YoY%
12.6-6.7-15.1-5.5-20.1-34.9-13.1-14.6-7.838.65.624.1
Expenses
ExpensesCr
535254586554646481657578
Operating Profit
Operating ProfitCr
3-11-5-17-20-28-21-30-39-28-30-35
OPM
OPM%
5.8-28.3-9.2-42.6-44.7-105.6-49.5-85.3-95.0-76.0-67.0-80.1
Other Income
Other IncomeCr
456456544557
Interest Expense
Interest ExpenseCr
211111223443
Depreciation
DepreciationCr
222234555666
PBT
PBTCr
1-10-2-17-20-27-22-44-45-25-36-41
Tax
TaxCr
6231101011-21
PAT
PATCr
-4-12-5-18-22-27-23-45-46-26-34-43
Growth YoY
PAT Growth YoY%
-167.9-192.8-167.1-6,292.9-416.0-120.9-383.6-149.2-113.74.9-49.93.9
NPM
NPM%
-7.4-30.0-9.6-44.0-47.9-101.9-53.1-128.4-111.0-69.9-75.4-99.4
EPS
EPS
-0.8-2.7-1.0-3.9-4.7-5.9-5.0-9.5-10.1-5.4-6.5-8.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
211121230201176145166
Growth
Revenue Growth%
-42.790.2-12.6-12.6-17.214.4
Expenses
ExpensesCr
216150231201230264299
Operating Profit
Operating ProfitCr
-5-29-11-54-119-132
OPM
OPM%
-2.5-23.7-0.50.3-31.0-81.5-79.4
Other Income
Other IncomeCr
39812191920
Interest Expense
Interest ExpenseCr
27241065814
Depreciation
DepreciationCr
81078101923
PBT
PBTCr
-87-64-18-3-49-139-147
Tax
TaxCr
5-11-27721
PAT
PATCr
-93-53-16-10-56-140-149
Growth
PAT Growth%
42.669.635.6-443.0-149.0-5.9
NPM
NPM%
-43.9-43.9-7.0-5.2-32.1-96.5-89.3
EPS
EPS
55.2-9.3-3.2-2.1-12.3-29.8-30.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
54545443434452
Reserves
ReservesCr
652599586495440305415
Current Liabilities
Current LiabilitiesCr
162226153161139165
Non Current Liabilities
Non Current LiabilitiesCr
157119645053109
Total Liabilities
Total LiabilitiesCr
1,024998858753684633838
Current Assets
Current AssetsCr
819728549459343261
Non Current Assets
Non Current AssetsCr
205270309294341372
Total Assets
Total AssetsCr
1,024998858753684633838

Cash Flow

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
-19736769-102-128
Investing Cash Flow
Investing Cash FlowCr
-586131812415947
Financing Cash Flow
Financing Cash FlowCr
557-73-94-119-29-13
Net Cash Flow
Net Cash FlowCr
-4812-107527-93
Free Cash Flow
Free Cash FlowCr
-209616466-121-152
CFO To PAT
CFO To PAT%
20.5-136.8-412.1-668.5181.590.9
CFO To EBITDA
CFO To EBITDA%
359.6-253.2-5,350.513,729.3188.1107.7

Ratios

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
0346397352853802
Price To Earnings
Price To Earnings
0.00.00.00.00.00.0
Price To Sales
Price To Sales
0.02.71.71.74.34.3
Price To Book
Price To Book
0.00.50.60.71.82.3
EV To EBITDA
EV To EBITDA
-23.9-14.3-333.1556.6-11.9-5.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
99.598.898.097.892.570.3
OPM
OPM%
-2.5-23.7-0.50.3-31.0-81.5
NPM
NPM%
-43.9-43.9-7.0-5.2-32.1-96.5
ROCE
ROCE%
-7.1-5.3-1.10.6-9.2-37.3
ROE
ROE%
-13.1-8.1-2.5-1.9-11.7-40.3
ROA
ROA%
-9.1-5.3-1.9-1.4-8.2-22.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview and Corporate Structure** Max India Limited (MIL) is the publicly listed holding company for the senior care and allied businesses within the $5 billion Max Group, one of India’s leading multi-business conglomerates. Following the demerger of non-healthcare assets from Max Healthcare in June 2020, MIL was reconstituted as the dedicated vehicle for the Group’s integrated senior care ecosystem. The company operates through two primary subsidiaries: - **Antara Senior Living Limited (ASLL)** – develops and manages independent living communities for seniors. - **Antara Assisted Care Services Limited (AACSL)** – delivers comprehensive medical and lifestyle care via Care Homes, Care at Home, and AGEasy. As of March 31, 2025, the Max Group employs approximately 26,000 people, operates ~500 offices across India, and serves ~4 million customers. Its consolidated revenue stood at **₹46,911 crores in FY25**, with core operations spanning life insurance (Max Life), real estate (Max Estates), and senior care under MIL. --- ### **Business Segments and Integrated Ecosystem** Max India’s strategy revolves around building a fully **integrated senior care ecosystem** that enables cross-selling and enhances customer lifetime value (LTV). The business is structured across two core divisions: #### 1. **Residences for Seniors** Antara offers luxury, independent, and assisted living communities designed for individuals aged 55+. Key projects include: - **Antara Dehradun** (flagship): A 14-acre community offering holistic wellness and lifestyle services. Sold out in Phase 1; remains cash surplus and profitable. - **Antara Noida** (Sector 150): A 340-apartment project developed in partnership with Contend Builders. Phase I is ready for possession. Fully sold out. - **Estate 360, Gurugram**: A 292-unit senior living component of Max Estates’ intergenerational project. Fully sold and operational. - **Future Developments**: Land parcels identified in **Gurugram (Phase II), Bangalore, Hyderabad, Chandigarh, Pune, and Goa**. Target of **8–10 integrated communities over the next 5–6 years**. The model blends healthcare, hospitality, insurance, and wellness into a "Lifestyle with Lifecare" proposition, focusing on physical, emotional, social, intellectual, and spiritual well-being. #### 2. **Assisted Care Services** Operated under Antara Assisted Care Services Limited, this vertical provides medical and supportive care for seniors with chronic or age-related conditions, through four key services: ##### a. **Care Homes** - Operates **6 facilities across Gurugram, Noida, Bengaluru, and Chennai**, with **~490 beds in total** (340 operational, ~150 nearing launch). - Full capacity target of **~500 beds by Q3 FY26**, rising to **2,000 beds over five years**. - Services include long-term medical supervision, short-term recuperative care, and recuperation post-surgeries or illness. - The Gurugram facility is **NABH-accredited**, with a specialization in **Memory Care for dementia and Parkinson’s patients**—India’s only such home. - Contribution margins have turned positive in multiple cities (Chennai: 5%, Bengaluru: 6%) due to improved occupancy and optimized operations. - Occupancy continues to ramp up: **Gurugram peaked at 68% in late 2023**, with break-even achieved at just 45% (better than planned 60%). Newer locations (e.g., Sector 24 Gurugram) at 20–25%, with strong growth trajectory expected. ##### b. **Care at Home** - Trained medical professionals deliver in-home care across **Delhi-NCR, Bengaluru, and Chennai**. - Generated **₹5.24 crores in net revenue in Q2 FY26**, a **21% YoY growth**. - Segment Q2 revenue in FY26 stood at **₹9.16 crores**, up 1.2x QoQ and 1.5x YoY in H1. - Q1 FY26 achieved record **₹4.94 crores in revenue**, with 24% YoY growth. - Bengaluru and Chennai markets showed **110% YoY revenue growth**, driven by high-margin offerings (critical care, physiotherapy). - Serves **3,400 patients in Q2 FY26**, with **37,000+ patients served cumulatively**. - Strategic focus remains on **higher-margin services, geographic expansion, and scaling clinical capabilities**. ##### c. **AGEasy** - Phyigital (physical + digital) direct-to-consumer platform offering senior-specific **non-prescription health products** to manage chronic conditions. - Focus areas: **Fall management (walkers, braces), Lung care (nebulizers, oximeters), and Joint pain (supports, bunion correctors)**. - Serves over **500,000 customers** (including 50,000 repeat), with **INR 20.9 crores in net revenue in Q2 FY26**. - Operates at a **monthly run rate of ₹7–8 crores**, up 1.5x QoQ. - H1 revenue in FY26: **INR 35 crores**, 3.3x YoY growth. - Distributes through **600+ retail and pharmacy outlets and 60 distributor partners across North India**, with South India expansion underway. - Key partnerships: - **Axle Bank** – leveraging 3 million Silver Linings customers for distribution; initial sales: 200,000 units. - **Boat** – co-developing senior-friendly electronics. - **Wellbeing Nutrition** – co-developing nutraceuticals for seniors (Vitamin D/B12 supplements). - Revenue model now fully aligned with **private-label Antara-branded products** (phased out third-party SKUs), improving margins. - Website redesigned for mobile-first experience. Platform GDPR/HIPAA-compliant with AWS cloud infrastructure. ##### d. **MedCare** (Now fully integrated into AGEasy) - Formerly offered rental and retail of medical equipment (walkers, wheelchairs, nebulizers). - Played a pivotal role in early growth; now embedded within AGEasy as part of the product and service stack. --- ### **Financial Highlights (FY25–FY26)** - **Care Homes**: - Q2 FY26 revenue: **₹3.91 crores** (+1.3x QoQ), H1 FY26: **₹6.84 crores** (~2.1x YoY). - FY25 revenue: **₹7.6 crores** (+38% YoY). - **Care at Home**: - Q2 FY26: **₹5.24 crores** (+21% YoY), H1 FY26: part of **₹17.02 crores total Assisted Care Services revenue**. - Q4 FY25: record **₹4.6 crores**, +52% YoY. - **AGEasy**: - Q1 FY26: **₹14.2 crores** (2.2x YoY growth). - Annualized run rate: **₹70–75 crores** (as of Aug 2025). - **Assisted Care Services (Aggregate)**: - Q2 FY26: **₹9.16 crores**, up 1.2x QoQ. - H1 FY26: **₹17.02 crores**, +1.5x YoY. - FY25: **₹65.2 crores in net revenue**, with a **run rate exceeding ₹100 crores** as of Mar 2025. - **Operational Margins**: - Overall business margin improved to **14% in Q4 FY25** (from 9% YoY), driven by service mix optimization and improved capacity utilization. - Care at Home NCR contribution margin: up from 19% to **25%**. --- ### **Strategic Initiatives and Growth Drivers** 1. **Technology Integration** - Implemented **ERP systems** and **mobile apps** for real-time monitoring and geo-fenced care tracking. - **MyAdda visitor management system** enhances resident security. - Integrated Property Management, POS, and Club Management systems ensure operational standardization. 2. **Geographic Expansion** - Entered **South India in FY24**, launching Care at Home and AGEasy in **Bangalore and Chennai**. - Aggressively expanding in **Hyderabad, Chandigarh, and Pune**; term sheets signed for major projects. 3. **Capital and Monetization Strategy** - Raised **₹43 crores for AGEasy** in FY24; plans new capital raise in 1–2 tranches over 12–18 months. - Pursuing **asset-light strategy** (Antara 2.0) through development management agreements (e.g., Noida, Estate 360). - Monetization of non-core land in Greater Noida underway. 4. **Marketing and Customer Acquisition** - Shifted to **digital-first marketing**: SEO, social media, WhatsApp, and email. - **Conversion rates improved** via hospital partnerships, doctor referrals, and webinars. - High **Net Promoter Scores (NPS)** and **resident referrals** (over 50% in Dehradun) driving organic growth.